Literature DB >> 2035693

Characterization of angiotensin receptors mediating prostaglandin synthesis in C6 glioma cells.

N Jaiswal1, D I Diz, E A Tallant, M C Khosla, C M Ferrario.   

Abstract

The heptapeptide angiotensin (ANG)-(1-7) mimics some but not all the central actions of ANG II, suggesting that receptor subtypes may exist. The effects of ANG-(1-7), ANG II, and ANG I on prostaglandin (PG) E2 and prostacyclin (PGI2) synthesis were investigated in neurally derived rat C6 glioma cells. All three ANG peptides stimulated PG release in a dose-dependent manner with the order of potency ANG-(1-7) greater than ANG I greater than ANG II. PGE2 release induced by ANG-(1-7) (10(-7) M) was partially blocked by [Sar1,Ile8]ANG II (10(-6) M), [Sar1,Thr8]ANG II (10(-6) M), or the subtype 1 selective antagonist Du Pont 753 (10(-5) M) but not by the subtype 2 selective antagonist CGP 42112A (10(-7)-10(-5) M). PGI2 release was inhibited only by [Sar1,Thr8]ANG II. ANG II-induced PGE2 release was blocked by [Sar1,Thr8]ANG II (10(-6) M), [Sar1,Ile8]ANG II (10(-6) M), or Du Pont 753 (10(-7) M) but not by CGP 42112A (10(-7)-10(-5) M). In contrast, ANG II-induced PGI2 release was blocked by Du Pont 753 (10(-7) M) as well as [Sar1,Ile8]ANG II (10(-6) M) but not by [Sar1,Thr8]ANG II or CGP 42112A. Thus ANG II-stimulated PGE2 and PGI2 syntheses in C6 glioma cells are mediated via receptor subtype 1. ANG-(1-7)-induced PGE2 synthesis is also mediated via subtype 1 receptors; however, PGI2 release was blocked by [Sar1,Thr8]ANG II only.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2035693     DOI: 10.1152/ajpregu.1991.260.5.R1000

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets.

Authors:  T Lau; P-O Carlsson; P S Leung
Journal:  Diabetologia       Date:  2004-01-13       Impact factor: 10.122

2.  Glucagon increase after chronic AT1 blockade is more likely related to an indirect leptin-dependent than to a pancreatic α-cell-dependent mechanism.

Authors:  Martin Mildner; Helge Müller-Fielitz; Ines Stölting; Olaf Jöhren; Muscha Steckelings; Walter Raasch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-01-31       Impact factor: 3.000

3.  Angiotensin II-dependent hypertension requires cyclooxygenase 1-derived prostaglandin E2 and EP1 receptor signaling in the subfornical organ of the brain.

Authors:  Xian Cao; Jeffrey R Peterson; Gang Wang; Josef Anrather; Colin N Young; Mallikarjuna R Guruju; Melissa A Burmeister; Costantino Iadecola; Robin L Davisson
Journal:  Hypertension       Date:  2012-02-27       Impact factor: 10.190

4.  Clearance and metabolism of arachidonic acid by C6 glioma cells and astrocytes.

Authors:  F Staub; A Winkler; J Peters; U Goerke; O Kempski; A Baethmann
Journal:  Neurochem Res       Date:  1995-12       Impact factor: 3.996

Review 5.  Angiotensin peptides and lung cancer.

Authors:  Patricia E Gallagher; Katherine Cook; David Soto-Pantoja; Jyotsana Menon; E Ann Tallant
Journal:  Curr Cancer Drug Targets       Date:  2011-05       Impact factor: 3.428

Review 6.  Pathologic consequences of increased angiotensin II activity.

Authors:  C M Ferrario; J M Flack
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

Review 7.  Systemic and uteroplacental renin--angiotensin system in normal and pre-eclamptic pregnancies.

Authors:  Lauren Anton; K Bridget Brosnihan
Journal:  Ther Adv Cardiovasc Dis       Date:  2008-10

Review 8.  Twenty years of progress in angiotensin converting enzyme 2 and its link to SARS-CoV-2 disease.

Authors:  Carlos M Ferrario; Sarfaraz Ahmad; Leanne Groban
Journal:  Clin Sci (Lond)       Date:  2020-10-16       Impact factor: 6.876

Review 9.  Local Renin-Angiotensin system in the reproductive system.

Authors:  Daniel Herr; Inga Bekes; Christine Wulff
Journal:  Front Endocrinol (Lausanne)       Date:  2013-10-18       Impact factor: 5.555

10.  Participation of Gαi-Adenylate Cyclase and ERK1/2 in Mas Receptor Signaling Pathways.

Authors:  Valeria Burghi; Emiliana B Echeverría; Máximo H Sosa; Diego T Quiroga; Marina C Muñoz; Carlos Davio; Federico Monczor; Natalia C Fernández; Fernando P Dominici
Journal:  Front Pharmacol       Date:  2019-02-22       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.